Machine learning‐driven diagnostic signature provides new insights in clinical management of hypertrophic cardiomyopathy
Abstract Aims In an era of evolving diagnostic possibilities, existing diagnostic systems are not fully sufficient to promptly recognize patients with early‐stage hypertrophic cardiomyopathy (HCM) without symptomatic and instrumental features. Considering the sudden death of HCM, developing a novel...
Wedi'i Gadw mewn:
| Prif Awduron: | , , , , , , , , , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Oxford University Press
2024-08-01
|
| Cyfres: | ESC Heart Failure |
| Pynciau: | |
| Mynediad Ar-lein: | https://doi.org/10.1002/ehf2.14762 |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|
